In contrast, cohort studies provide better-defined populations and follow-up but remain vulnerable to subjective reporting and confounding
Glucagon-like peptide-1 (GLP-1) is a hormone released in your intestines in response to eating
Weight loss results were favorable as well for tirzepatide
Memorial Sloan Kettering Cancer Center
An observational study performed among 303 participants with and without T2DM who underwent computed tomography (CT) angiography due to chest pain, reported a positive association of endogenous GLP-1 levels with coronary plaque burden ( In addition to direct actions in coronary arteries, GLP-1 RAs can prevent the formation and progression of coronary atherosclerosis through indirect mechanisms, such as maintaining glycemic control, losing weight, decreasing systolic blood pressure, obtaining beneficial effects from lipid levels, inhibiting platelet activation, reducing systemic inflammation and levels of circulating BNP ( Glucagon-Like Peptide 1 Receptor Agonists and Vasospasm of Epicardial Coronary Arteries Spasms in the smooth muscle layer of the coronary artery wall can be focal or diffuse, resulting in vasospastic angina or myocardial infarction (MI), respectively